Montemayor, Jaime
Sarva, Harini
Kelly-Blake, Karen
Cabrera, Laura Y.
Article History
Received: 5 November 2021
Accepted: 10 April 2022
First Online: 24 April 2022
Declarations
:
: Institutional Review Board approval was obtained from Michigan State University (Study00002041) and Weill Cornell Medicine (Protocol#1901019902). The study was performed in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: After receiving information regarding the study, continuation to the survey questions was considered implied consent.
: JM: None.HS: Has financial disclosures unrelated to this work. She has received clinical trial support from Biogen, Lundbeck, Intec, Insightec, Neuroderm, Prevail and Covance pharmaceuticals as well as some research support from the Michael J. Fox Foundation and the NIH. In addition, she has served as a consultant for Merz, Accorda, Neurocrine, CALA health, Amneal, Novo Nordisk Pharmaceuticals.KKB: None.LYC: None.
: None.